STAT Plus Pharmalittle Novo launches plan to lower insulin costs; Sprout gets a win from FDA for female libido pill

STAT Plus: Pharmalittle: Novo launches plan to lower insulin costs; Sprout gets a win from FDA for female libido pill

Sprout Pharmaceuticals cheered a decision by the FDA to remove a ban on alcohol use with Addyi pill for female libido pill.

More From BioPortfolio on "STAT Plus: Pharmalittle: Novo launches plan to lower insulin costs; Sprout gets a win from FDA for female libido pill"